Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus
Navid Ezra, Joseph L. Jorizzo
Clinical and Experimental Dermatology (2012) Vol. 37, Iss. 4, pp. 327-334
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier, Thomas Dörner
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 3, pp. 155-166
Open Access | Times Cited: 1317
Cutaneous lupus erythematosus: Diagnosis and treatment
L.G. Okon, Victoria P. Werth
Best Practice & Research Clinical Rheumatology (2013) Vol. 27, Iss. 3, pp. 391-404
Open Access | Times Cited: 271
Cutaneous Manifestations of Systemic Lupus Erythematosus
Luís Uva, Diana Miguel, Catarina Pinheiro, et al.
Autoimmune Diseases (2012) Vol. 2012, pp. 1-15
Open Access | Times Cited: 119
Influence of smoking on the efficacy of antimalarials in cutaneous lupus: A meta-analysis of the literature
François Chasset, Camille Françès, Stéphane Barète, et al.
Journal of the American Academy of Dermatology (2015) Vol. 72, Iss. 4, pp. 634-639
Closed Access | Times Cited: 103
Environmental Factors, Toxicants and Systemic Lupus Erythematosus
Anselm Mak, Sen Hee Tay
International Journal of Molecular Sciences (2014) Vol. 15, Iss. 9, pp. 16043-16056
Open Access | Times Cited: 91
The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study
François Chasset, Laurent Arnaud, N. Costedoat‐Chalumeau, et al.
Journal of the American Academy of Dermatology (2016) Vol. 74, Iss. 4, pp. 693-699.e3
Open Access | Times Cited: 70
Cigarette smoking, alcohol consumption and risk of systemic lupus erythematosus
Samuel U Takvorian, Joseph F. Merola, KH Costenbader
Lupus (2014) Vol. 23, Iss. 6, pp. 537-544
Closed Access | Times Cited: 56
Updated recommendations on the use of hydroxychloroquine in dermatologic practice
Anthony P. Fernandez
Journal of the American Academy of Dermatology (2017) Vol. 76, Iss. 6, pp. 1176-1182
Open Access | Times Cited: 50
Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature
Martin Klebes, Nora Wutte, Elisabeth Aberer
Dermatology (2015) Vol. 232, Iss. 1, pp. 91-96
Closed Access | Times Cited: 42
Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus
Alexandra Legge, Steve Doucette, John G. Hanly
The Journal of Rheumatology (2016) Vol. 43, Iss. 6, pp. 1050-1056
Closed Access | Times Cited: 40
Hydroxychloroquine in dermatology and beyond: Recent update
Surabhi Sinha, Kabir Sardana, Soumya Sachdeva
Indian Dermatology Online Journal (2020) Vol. 11, Iss. 3, pp. 453-453
Open Access | Times Cited: 33
Efficacy and Safety of Biologic Therapies for Systemic Lupus Erythematosus Treatment: Systematic Review and Meta-Analysis
Helena Hiemisch Lobo Borba, Astrid Wiens, Thaís Teles de Souza, et al.
BioDrugs (2013) Vol. 28, Iss. 2, pp. 211-228
Closed Access | Times Cited: 33
Trigger factors of cutaneous lupus erythematosus: a review of current literature
Justyna Szczęch, Dominik Samotij, Victoria P. Werth, et al.
Lupus (2017) Vol. 26, Iss. 8, pp. 791-807
Closed Access | Times Cited: 31
An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review
William Shipman, Nicholas A. Vernice, Michelle Demetres, et al.
Journal of the American Academy of Dermatology (2019) Vol. 82, Iss. 3, pp. 709-722
Closed Access | Times Cited: 28
Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
Jucelio Pereira Moura Filho, Raiza Luna Peixoto, Livia Gomes Martins, et al.
Anais Brasileiros de Dermatologia (2014) Vol. 89, Iss. 1, pp. 118-125
Open Access | Times Cited: 28
Association Between Cigarette Smoking and Systemic Lupus Erythematosus: An Updated Multivariate Bayesian Metaanalysis
Monica Hui Yan Chua, Irene Ai Ting Ng, Mike W.‐L. Cheung, et al.
The Journal of Rheumatology (2019) Vol. 47, Iss. 10, pp. 1514-1521
Closed Access | Times Cited: 25
Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model
Jianling Yang, Zhengyang Guo, Xu Liu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 22
An update on the management of refractory cutaneous lupus erythematosus
Alice Verdelli, Alberto Corrà, Elena Biancamaria Mariotti, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Binding of chloroquine to ionic micelles: Effect of pH and micellar surface charge
Marcela de Souza Santos, Maria Perpétua Freire de Morais Del Lama, Amando Siuiti Ito, et al.
Journal of Luminescence (2013) Vol. 147, pp. 49-58
Closed Access | Times Cited: 26
Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus
Warren Raymond, Matthew Hamdorf, M Furfaro, et al.
Lupus Science & Medicine (2021) Vol. 8, Iss. 1, pp. e000537-e000537
Open Access | Times Cited: 17
Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized
Michael E. Farhangian, William W. Huang, Steven R. Feldman
Dermatology and Therapy (2015) Vol. 5, Iss. 2, pp. 91-105
Open Access | Times Cited: 14
Association of discoid lupus erythematous with substance use disorders: A case–control study in the all of us database
Tejas P. Joshi, T. Austin Black, Anthony Duruewuru, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 11
Closed Access | Times Cited: 1
Polymorphisms in NAT2 (N-acetyltransferase 2) gene in patients with systemic lupus erythematosus
Elaine Cristina Lima dos Santos, Amanda Chaves Pinto, Evandro Mendes Klumb, et al.
Revista Brasileira de Reumatologia (English Edition) (2016) Vol. 56, Iss. 6, pp. 521-529
Open Access | Times Cited: 9
Smoking and rheumatoid arthritis
Anna Litwic, Christopher J Edwards
(2013), pp. 230-242
Closed Access | Times Cited: 7
Polimorfismos no gene NAT2 (N‐acetiltransferase 2) em pacientes com lúpus eritematoso sistêmico
Elaine Cristina Lima dos Santos, Amanda Chaves Pinto, Evandro Mendes Klumb, et al.
Revista Brasileira de Reumatologia (2016) Vol. 56, Iss. 6, pp. 521-529
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top